Hubbry Logo
Bouin solutionBouin solutionMain
Open search
Bouin solution
Community hub
Bouin solution
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Bouin solution
Bouin solution
Bouin solution
View on Wikipedia
from Wikipedia

Bouin solution, or Bouin's solution, is a compound fixative used in histology.[1] It was invented by French biologist Pol Bouin and is composed of picric acid, acetic acid and formaldehyde in an aqueous solution.[2] Bouin's fluid is especially useful for fixation of gastrointestinal tract biopsies because this fixative allows crisper and better nuclear staining than 10% neutral-buffered formalin. It is not a good fixative when tissue ultrastructure must be preserved for electron microscopy. However, it is a good fixative when tissue structure with a soft and delicate texture must be preserved. The acetic acid in this fixative lyses red blood cells and dissolves small iron and calcium deposits in tissue. A variant in which the acetic acid is replaced with formic acid can be used for both fixation of tissue and decalcification.[3] The effects of the three chemicals in Bouin solution balance each other. Formalin causes cytoplasm to become basophilic but this effect is balanced by the effect of the picric acid. This results in excellent nuclear and cytoplasmic H&E staining. The tissue hardening effect of formalin is balanced by the soft tissue fixation of picric and acetic acids. The tissue swelling effect of acetic acid is balanced by the tissue shrinking effect of picric acid.[4]

Hydrated sections of formaldehyde-fixed tissue are usually pre-treated with Bouin solution to obtain correct results in the trichrome stains for contrasting colours in collagenous and cytoplasmic (muscle) fibres. The trichrome methods were devised for tissues fixed in acidic mixtures containing mercuric chloride, which are now used only on a small scale.) Only the picric acid component of Bouin's solution is needed to bring about this correction of trichrome staining.[5]

When using Bouin solution, several potential problems can arise. Due to the formalin in the solution, formalin pigment may be present when viewing tissue sections under the microscope. Wet tissue should be fixed in Bouin solution for less than 24 hours. Excess picric acid should be washed out of tissue using several alcohol and water solutions or staining quality may deteriorate over time. Wet tissue fixed in Bouin solution should be stored in an alcohol and water solution rather than Bouin solution. Since Bouin solution contains formaldehyde, picric acid and acetic acid, appropriate safety precautions for these substances should be taken and regulations followed. In particular, noting that picric acid can be explosive, sensitive to friction and shock when dry and in contact with some metals can form unstable metal picrates.

Under the name "Bouin's fluid" this fixative is also widely used for marine invertebrates.[6] It is prepared as follows: picric acid, saturated aqueous solution – 75 ml; formalin, 40% aqueous solution – 25 ml; acetic acid, glacial – 5 ml.[7]

Variations

[edit]

Gendre solution

[edit]

Gendre solution is an alcoholic version of Bouin solution. An alcoholic solution saturated with picric acid is used instead of an aqueous solution saturated with picric acid when making this solution. This solution is useful when glycogen and other carbohydrates must be preserved in tissue. It is prepared by a mixing saturated solution of picric acid in 95% ethanol (80ml) with formalin (37-40% formaldehyde) (15 ml) and glacial acetic acid (5ml).[8] Gendre's fixative contains more picric acid than Bouin's, because of greater solubility (6.23%w/v) in ethanol than in water (1.23%w/v).[9]

Hollande solution

[edit]

Hollande solution is a version of Bouin solution that contains copper acetate. The copper acetate stabilizes red blood cell membranes and the granules of eosinophils and endocrine cells so that there is less lysis of these cell components than occurs in regular Bouin solution.[10] Hollandes fixative is made by adding 6.25g cupric acetate, 10g picric acid (wet powder), 25ml formalin (37-40% formaldehyde) and 2.5 ml glacial (100%) acetic acid to 250ml water.[11]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Bouin solution

View on Grokipedia
from Grokipedia
Bouin solution, also known as Bouin's fixative, is a compound fixative widely used in for preserving tissue morphology, particularly in delicate specimens. Invented by French biologist Pol André Bouin in 1897, it consists of a saturated of (approximately 75 parts), 40% (25 parts), and glacial acetic acid (5 parts), which together provide rapid penetration and fixation while minimizing tissue distortion. This fixative excels in applications involving soft and fragile tissues, such as biopsies from the , testes, lymph nodes, , kidneys, endocrine organs, embryos, and , where it offers superior preservation of nuclear detail, chromosomes, and cytological features compared to alternatives like formalin. It is especially compatible with hematoxylin and eosin (H&E) and serves as an effective in trichrome procedures, enhancing contrast in connective tissues. Additionally, Bouin solution's acidic components allow it to function in when tissues are immersed for extended periods (several days to weeks), making it versatile for both fixation and preparatory processing in pathological examinations. While it provides crisp nuclear and reduced autolysis in gastrointestinal samples, it can cause tissue shrinkage and imparts a tint due to , necessitating thorough washing before further processing; also poses explosion risks if allowed to dry.

Overview

Definition and Purpose

Bouin solution is a compound fixative employed in to preserve the morphological structure of biological tissues with minimal distortion. It is particularly valued for its ability to maintain the architectural integrity of delicate cellular components, making it suitable for a range of histological applications. The primary purpose of Bouin solution is to stabilize soft and delicate structures, such as embryos, gonads, and endocrine tissues, by inhibiting autolytic enzymes and preventing post-mortem degradation processes like . This fixation process crosslinks proteins to halt enzymatic breakdown, ensuring that tissues retain fine details essential for accurate analysis. By preserving and nuclear structures effectively, it supports the study of tissues that are prone to rapid deterioration. In preparation for microscopic examination, Bouin solution facilitates enhanced staining outcomes, providing vivid nuclear detail and compatibility with techniques like for evaluating tissue fibrosis. Developed by French biologist Pol André Bouin in 1897, it remains a standard tool for readying specimens from the , , and other fragile samples for detailed histological scrutiny.

Basic Mechanism

While the overall mechanism of Bouin's solution is not fully understood, it functions as a compound fixative in histology through the synergistic actions of , cross-linking, and processes that stabilize tissue architecture without excessive hardening or distortion. Its components—, , and acetic acid—collectively precipitate and link proteins while minimizing shrinkage and enhancing penetration into delicate structures. This allows for sharp morphological detail, particularly in nuclear and cytoplasmic features, making it suitable for tissues prone to artifactual changes. Picric acid penetrates tissues and coagulates proteins by forming insoluble picrate salts with basic , which helps precipitate and stabilize cellular components without the brittleness associated with purely coagulant fixatives. It also contributes to tissue shrinkage, counteracting swelling from other elements and enhancing nuclear contrast during subsequent staining. , acting as a cross-linking agent, forms methylene bridges between protein residues such as , thereby reinforcing the structural integrity of tissues and preserving overall morphology. Acetic acid complements these actions by promoting rapid into the sample, causing swelling to balance shrinkage induced by the other components, while precipitating nucleic acids to prevent excessive hardening. This multifaceted approach excels in preserving and fine cytoplasmic structures better than many single-component fixatives, such as neutral buffered formalin, by avoiding aggressive that could disrupt delicate organelles or matrices. The result is enhanced visibility of subcellular details, including granules and cytoplasmic filaments, which remain intact for histochemical analysis. Overall, Bouin solution's balanced approach yields tissues with superior morphological fidelity, particularly for endocrine, gastrointestinal, and embryonic specimens.

History and Development

Inventor and Invention

Pol André Bouin (1870–1962) was a French histologist and whose contributions to and reproductive shaped early 20th-century . Born in 1870, Bouin studied medicine and pursued a career at the Faculty of Medicine in , where he specialized in histological techniques and endocrine functions. Collaborating with Paul Albert Ancel from 1897 to 1904, he conducted pioneering studies on Leydig cells and their role in testicular physiology, emphasizing the need for precise tissue preservation to visualize cellular structures under emerging microscopic technologies. In 1897, Bouin developed a picrate-based fixative that revolutionized tissue preparation in , addressing key shortcomings of prevailing methods. At the time, alcohol-based fixatives often caused excessive tissue shrinkage, hardening, and artifacts due to their lack of protein crosslinking, limiting their use to small fragments and complicating detailed microscopic examination. Simple acid fixatives, meanwhile, degraded nucleic acids, produced poorly hardened tissues difficult to section, and frequently incorporated toxic , hindering accurate and analysis. Bouin's innovation emerged amid rapid advancements in and techniques during the late , such as the integration of (introduced medically around 1891), which spurred efforts to create compound fixatives for superior morphological preservation, particularly of nuclear details in delicate tissues like testes. This fixative, later eponymously named Bouin's solution, was specifically designed to enhance nuclear and chromosomal visibility, making it invaluable for early diagnostic applications in reproductive and lymphatic tissues. Its creation reflected Bouin's practical expertise in overcoming the era's fixation challenges, enabling clearer histological insights that supported his own endocrine research and broader advancements in .

Historical Impact

Following its , Bouin solution saw widespread in early 20th-century histological , especially within French-speaking scientific communities, where it was favored over formalin for diagnostic purposes in fields like , , and . This uptake was driven by Pol Bouin's collaboration with Paul Ancel from 1897 to 1904 at the Faculty of Medicine in , where the fixative facilitated groundbreaking studies on endocrine functions in reproductive organs across various animal species and humans. Their joint efforts, detailed in a seminal 1903 publication featuring high-quality illustrations, established Bouin solution as an essential tool for preserving delicate cellular structures in these disciplines. The fixative's superior nuclear preservation enabled detailed microscopic examinations of Leydig cells in testes and ovarian tissues, providing critical insights that shaped early understandings of reproductive and hormonal regulation. Bouin solution also emerged as the standard in protocols, allowing for enhanced differentiation of connective tissues and cellular components in histological sections, which broadened its utility beyond initial reproductive studies. Bouin solution's legacy endures in contemporary histology as of 2025, maintaining a niche role in institutions worldwide for fixating soft and embryonic tissues despite the dominance of neutral-buffered formalin. Its formulation has influenced the evolution of subsequent fixatives by emphasizing balanced preservation of morphology and biomolecules, with recent investigations highlighting its effectiveness in maintaining ovarian tissue morphology. As of 2024, studies continue to explore its applications in preserving ovarian and other delicate tissues for morphological analysis.

Chemical Composition

Ingredients

Bouin solution is a histologic fixative composed of three primary ingredients: saturated aqueous , 40% , and glacial acetic acid. These components work synergistically to preserve tissue morphology, with each contributing distinct chemical properties essential for effective fixation. Saturated aqueous serves as a and protein coagulant, facilitating deep penetration into tissues and preserving color while forming salts with proteins to induce . This action helps maintain structural integrity without excessive hardening. 40% acts as a cross-linking agent, stabilizing proteins by forming methylene bridges that prevent degradation and autolysis. Glacial acetic acid functions as a shrinkage corrector and nuclear fixative, counteracting tissue swelling by precipitating nucleoproteins and enhancing nuclear detail. The combination of these ingredients yields a balanced fixative particularly suited for delicate tissues, as the coagulative effects of and acetic acid offset the hardening from , resulting in optimal preservation for subsequent staining.

Proportions and Properties

The standard proportions of Bouin solution consist of 75 parts saturated aqueous (approximately 1.2% w/v), 25 parts 40% , and 5 parts glacial acetic acid, yielding a total volume often standardized to 100 parts for preparation. These ratios ensure balanced fixation, with the component providing the primary staining and protein-coagulating effects, while contributes cross-linking and acetic acid enhances nuclear preservation. Physically, Bouin solution is a liquid owing to the , with an acidic typically ranging from 1 to 2, attributed to the glacial acetic acid and the overall composition. Its specific gravity is around 1.04, reflecting the contributed by the dissolved components in an aqueous base. The solution exhibits a pungent from the and acetic acid volatiles. Chemically, Bouin solution demonstrates good stability in its prepared aqueous form under normal storage conditions, preventing rapid degradation of the active ingredients. However, the component renders the solution potentially hazardous if allowed to evaporate to dryness, as pure picric acid can form explosive crystals sensitive to shock or friction. This stability in solution supports its utility as a fixative without immediate reactive hazards during typical histological use.

Preparation Methods

Standard Procedure

The standard procedure for preparing Bouin solution begins with the creation of a saturated aqueous solution, which serves as the base component. To achieve saturation, add solid picric acid crystals to at room temperature until no more dissolves, typically resulting in a concentration of approximately 1.3% w/v; this process may take 2-3 days with occasional stirring, after which the solution is filtered to remove undissolved particles. For a standard batch yielding approximately 100 ml of Bouin solution, combine 75 ml of the saturated solution with 25 ml of 40% (formalin) in a suitable , stirring gently to mix at . Immediately before use, add 5 ml of glacial acetic acid and mix thoroughly but gently to avoid excessive agitation, which could introduce air bubbles or instability. To prepare 1 liter of Bouin solution, scale the proportions proportionally: use 714 ml saturated solution, 238 ml 40% , and 48 ml glacial acetic acid, following the same sequential mixing order at room temperature. For smaller batches, such as 50 ml, reduce volumes by half (e.g., 37.5 ml solution, 12.5 ml , 2.5 ml acetic acid) while maintaining the 15:5:1 ratio to ensure consistency. Upon completion, verify the quality of the solution by checking for a clear, bright color indicative of proper dissolution and homogeneity; if the solution appears cloudy or contains precipitates, filter it through Whatman No. 1 or equivalent to achieve clarity before use.

Safety and Storage

Bouin solution poses significant health and safety risks primarily due to its key components: , , and glacial acetic acid. becomes highly explosive when dry (containing less than 10% water) and can form sensitive explosive salts upon contact with metals; it is also a strong skin irritant capable of causing dermatitis and allergic reactions. is classified as a by the International Agency for Research on Cancer, with potential to cause respiratory irritation, sensitization, and long-term cancer risks via inhalation or skin contact. Glacial acetic acid is corrosive, leading to severe burns on skin, eyes, and mucous membranes upon exposure. Safe handling requires strict precautions to minimize exposure. All work with Bouin solution must be performed in a well-ventilated to avoid of vapors. (PPE) including chemical-resistant gloves (double-gloving recommended), splash-proof goggles, a coat, long pants, and closed-toe shoes is essential. After handling, thoroughly wash skin with soap and water, and avoid eating, drinking, or smoking in the area. Spills should be contained with absorbent materials wetted with water, neutralized if possible, and cleaned up by trained personnel without direct contact. For waste disposal, neutralize the solution with or to reduce acidity and reactivity before collection as hazardous chemical waste in accordance with local regulations; never pour down drains or mix with other wastes. Proper storage is critical to maintain stability and prevent hazards. Bouin solution should be kept in tightly sealed, original plastic or glass containers in a cool, dry, well-ventilated area away from direct sunlight, heat sources, ignition points, strong bases, oxidizers, and metals to avoid explosive reactions or degradation. Recommended storage temperature is 15-30°C, where the solution remains stable for up to 2 years from the date of manufacture. Always ensure the solution remains wet to mitigate picric acid explosion risks; if evaporation occurs or the container is compromised, treat as hazardous and contact safety personnel. Regularly inspect for signs of instability, such as precipitation or unusual odor changes, and discard per hazardous waste protocols if degradation is evident.

Applications in Histology

Tissue Fixation Process

The tissue fixation process using Bouin solution begins with the immediate immersion of fresh tissue samples, ideally sliced to 1-5 mm thickness to ensure adequate penetration, in the fixative at room temperature. Fixation duration typically ranges from 4 to 18 hours, varying by tissue type and size, with optimal results achieved within 24 hours to avoid over-fixation and brittleness; for instance, small specimens may require only 4-6 hours, while larger ones benefit from up to 48 hours if monitored. Perfusion fixation prior to immersion can be used for whole organs, followed by immersion, to enhance uniformity. Following fixation, tissues must be thoroughly washed to remove residual , which imparts a color; this is accomplished by rinsing in running for at least 1 hour or in multiple changes of 70% until no tint exudes from the sample. Fixed tissues can be stored short-term in 70% or 10% formalin before further processing. Bouin solution yields excellent preservation of nuclear chromatin and cytoplasmic structures, providing sharp morphological detail suitable for subsequent histological analysis. It induces slight tissue shrinkage due to the picric acid component, which nonetheless enhances overall structural clarity without excessive distortion. Post-fixation processing involves dehydration through a graded series of ethanol solutions (70% to absolute), clearing in xylene or a substitute, and embedding in paraffin wax for microtome sectioning, enabling the production of thin slices (typically 4-6 μm) for microscopic examination. The mechanism of preservation relies on the synergistic action of formalin for protein cross-linking and picric acid for softening and staining enhancement.

Staining Compatibility

Bouin solution serves as an ideal for techniques, particularly Masson's trichrome, where it enhances the differentiation of s by improving contrast between and cellular components in fixed specimens. This compatibility stems from the component, which binds to proteins and facilitates brighter, more selective dye uptake during the staining process, making it a preferred fixative for routine connective tissue evaluation. In hematoxylin and eosin (H&E) , Bouin-fixed tissues exhibit enhanced nuclear detail, with crisper patterns and better overall nuclear contrast compared to formalin-fixed samples, allowing for superior visualization of gastrointestinal biopsies and soft tissues. For periodic acid-Schiff (PAS) , Bouin solution preserves effectively, yielding strong, reliable demonstration of in hepatic and other glycogen-rich tissues, often outperforming other fixatives in staining intensity at both room and refrigerated temperatures. Bouin fixation also supports improved visualization of the Golgi apparatus in paraffin-embedded sections, enabling clearer morphological assessment through compatible silver impregnation or immunocytochemical methods post-fixation. However, due to residual imparting a yellow tint that can interfere with subsequent stains, tissues require thorough removal via a picric acid-alcohol —typically involving running rinses followed by immersion in 70% for at least 15 minutes—prior to dehydration and staining to ensure optimal color fidelity and tissue clarity.

Advantages and Disadvantages

Key Benefits

Bouin solution offers significant advantages in the fixation of delicate tissues, where it provides superior preservation of morphological details with minimal distortion. It is particularly effective for embryos, testes, and brain tissue, yielding sharp cytoplasmic and nuclear delineation that enhances subsequent microscopic examination. This is achieved through the balanced action of its acidic and protein-coagulating components, which stabilize cellular structures without excessive hardening or shrinkage, outperforming neutral buffered formalin in maintaining fine architectural features. A key strength of Bouin solution lies in its ability to retain and other carbohydrates during fixation, in contrast to formalin-based alternatives that often result in partial extraction or degradation of these molecules. This preservation is essential for histological studies involving carbohydrate-rich tissues, such as liver or muscle, where accurate localization and quantification of are required. The in the formulation plays a crucial role in stabilizing these by promoting rapid penetration and cross-linking without dissolution. The solution's yellow coloration, derived from , provides a practical benefit by imparting a visible tint to fixed tissues, which helps identify unfixed regions during and ensures even penetration. This effect allows histologists to assess fixation completeness visually, reducing the risk of incomplete preservation in heterogeneous samples.

Limitations and Alternatives

Despite its utility in certain histological applications, Bouin solution has notable limitations, particularly in advanced diagnostic techniques. The presence of interferes with antigen retrieval and masking during (IHC), often resulting in poor preservation of immunoreactivity for many markers, making it unsuitable for routine IHC studies. Additionally, while Bouin solution can facilitate decalcification of hard tissues through its acidic components, the process is slow, requiring immersion for several days to weeks to achieve adequate demineralization without dedicated decalcifiers. Picric acid also poses significant environmental and safety challenges in laboratory settings. As a hazardous substance, it is classified as when dry and mutagenic, necessitating specialized handling and disposal protocols, such as neutralization or treatment as , which increases operational costs and regulatory compliance burdens. Common alternatives to Bouin solution include neutral buffered formalin (NBF), which is widely preferred for IHC due to better preservation and compatibility with molecular assays, though it may compromise some morphological details in delicate tissues. For and hematopoietic tissues, Zenker's fixative offers superior nuclear detail and fixation speed without , serving as a mercury-based substitute in specialized protocols. Non-picric fixatives, such as commercial Bouin's substitutes, are used to mitigate safety hazards associated with .

Variations

Gendre Solution

The Gendre solution represents an alcoholic variant of the Bouin fixative, adapted for enhanced performance in specific histological applications. Its composition substitutes aqueous components with alcohol to facilitate quicker tissue penetration: it consists of 800 mL of 95% saturated with , 150 mL of 40% (formalin), and 50 mL of glacial acetic acid. This formulation replaces the water in the standard Bouin mixture with 80-90% , promoting rapid diffusion into tissues while maintaining the core fixative properties of , formalin, and acetic acid. The primary purpose of the Gendre solution is to improve the preservation of and other carbohydrates in histological specimens, where standard fixatives may lead to degradation. It is particularly useful for applications involving soft tissues, such as in cytology smears from , where maintaining structural integrity of carbohydrate-rich components is essential. Additionally, the alcoholic base helps reduce aging effects in the fixative solution itself, allowing for more stable storage and consistent results over time compared to aqueous versions. Key advantages of the Gendre solution over the standard Bouin fixative include superior suitability for rapid fixation and smear preparations, with typical fixation times ranging from 1 to 4 hours for small samples to avoid over-fixation. The component accelerates penetration, making it ideal for delicate or thin tissues that require quick processing without compromising retention, which is often better preserved through protein trapping or precipitation mechanisms facilitated by the alcohol-picric acid interaction. Tissues should not be left in the solution for extended periods to prevent excessive hardening.

Hollande Solution

The Hollande solution is a modified variant of the Bouin fixative, incorporating copper acetate to enhance stability and provide mild decalcification properties. This addition typically involves 25 grams of copper acetate dissolved in approximately 1 liter of , alongside the standard Bouin's components of saturated aqueous , , and glacial acetic acid. The copper acetate, present at concentrations around 2-2.5% in prepared solutions, stabilizes cellular structures such as membranes and cytoplasmic granules, making it particularly suitable for preserving delicate tissues. This fixative is especially ideal for the fixation of bone specimens, where its mild decalcifying action facilitates subsequent processing without compromising morphology, as well as endocrine tissues and gastrointestinal tract biopsies containing inflammatory or mucinous cells. It excels in applications requiring enhanced histochemical staining, providing superior preservation of cellular details and enzyme activity compared to standard fixatives in these contexts. Tissues fixed in Hollande solution demonstrate excellent compatibility with silver impregnation techniques for protozoans like flagellates and ciliates, and it supports routine histological examinations of complex structures. Compared to the standard Bouin solution, Hollande offers a longer and greater stability under normal conditions (15-30°C), reducing the need for frequent preparation and minimizing degradation of active components. It also shows improved compatibility with (IHC) in certain protocols, preserving antigenicity while maintaining tissue architecture, though results can vary by . Fixation times typically range from 6 to 24 hours for most surgical specimens, allowing for efficient processing without over-fixation artifacts.

References

  1. https://www.researchgate.net/publication/21657192_Pol_Andre_Bouin_MD_1870-1962_Bouin%27s_fixative_and_other_contributions_to_medicine
  2. https://www.leicabiosystems.com/us/knowledge-pathway/fixation-and-fixatives-4-popular-fixative-solutions/
  3. https://www.emsdiasum.com/bouins-solution
  4. https://microscopy.arizona.edu/learn/bouins-fixative
  5. https://www.clinisciences.com/en/buy/cat-bouin-s-solution-for-histology-5364.html
  6. https://bitesizebio.com/13444/histology-fixatives-what-do-they-actually-do-to-your-samples/
  7. https://www.sigmaaldrich.com/US/en/product/sigma/ht10132
  8. https://www.sciencedirect.com/topics/medicine-and-dentistry/bouin-solution
  9. https://www.deltamicroscopies.com/en/products/bouins-fixative/
  10. https://pubmed.ncbi.nlm.nih.gov/1497471/
  11. https://webpath.med.utah.edu/HISTHTML/HISTOTCH/HISTOTCH.html
  12. https://biomedres.us/pdfs/BJSTR.MS.ID.007563.pdf
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC4240801/
  14. https://waxitinc.com/fixing-tissue-for-optimal-results-part-1/
  15. https://www.researchgate.net/publication/328062174_The_use_of_fixative_solutions_throughout_the_ages_a_comprehensive_review
  16. https://academic.oup.com/humrep/article/36/7/1871/6270965
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC10967444/
  18. https://embryology.med.unsw.edu.au/embryology/index.php/Histology_Fixatives
  19. https://theolb.readthedocs.io/en/latest/histology/bouins-fluid-fixation.html
  20. https://www.mercedesscientific.com/mercedes-scientific-bouin-s-fluid-125ml
  21. https://shop.leicabiosystems.com/en-fr/actions/ViewProductAttachment-OpenFile?LocaleId=en_US&DirectoryPath=HC%2BDocuments%252FLeica%2BGomoris%2BTrichome%2BSpecial%2BStain%2BKit%2B%2528Blue%2Bcollagen%2529%252FMaterial_Safety_Data_Sheets&FileName=Bouin_s_Solution_EN.pdf&UnitName=LBS
  22. https://www.statlab.com/pdfs/sds/Bouins_Solution_Safety_Data_Sheet.pdf
  23. https://pubchem.ncbi.nlm.nih.gov/compound/Picric-Acid
  24. https://www.sigmaaldrich.com/US/en/product/sigma/p6744
  25. https://ihcworld.com/2024/01/25/fixative-protocols-and-recipes/
  26. https://www.bio-rad-antibodies.com/fixative-recipes.html
  27. https://mmegias.webs.uvigo.es/02-english/6-tecnicas/protocolos/s-fijador-bouin.php
  28. https://ehs.stanford.edu/reference/information-picric-acid
  29. https://www.sigmaaldrich.com/US/en/sds/sigma/ht10132
  30. https://www.agilent.com/cs/library/msds/SDS021_NAEnglish.pdf
  31. https://www.newcomersupply.com/product/bouin-fluid-fixative/
  32. https://www.fishersci.com/shop/products/bouins-fluid-fixative-1-gal/NC0827069
  33. https://medicine.yale.edu/compmed/mrp/fixationprotocols/
  34. https://tools.thermofisher.com/content/sfs/manuals/D21495~.pdf
  35. https://webpath.med.utah.edu/HISTHTML/MANUALS/BOUIN.PDF
  36. https://www.mmcri.org/deptPages/fac/downloads/HistologyProtocols.pdf
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6940599/
  38. https://www.sigmaaldrich.com/TP/en/product/sigma/ht101128
  39. https://www.reprocell.com/resources/protocols/alvetex-scaffold/d049-histology-3-bouins-fix-embed-staining
  40. https://www.saffronscientific.com/masson-trichrome-technique-tricks/
  41. https://www.cancerdiagnostics.com/Bouins-Fluid-Solution-SSC1053
  42. https://pubmed.ncbi.nlm.nih.gov/20214545/
  43. https://journals.sagepub.com/doi/pdf/10.1177/38.7.2355176
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC5028485/
  45. https://www.fishersci.com/shop/products/bouins-fixative-substitute/NC9772216
  46. https://www.stainsfile.com/fixatives/gendres-fixative/
  47. https://quizlet.com/405761348/histopathology-fixation-pt1-flash-cards/
  48. https://www.stainsfile.com/fixatives/hollandes-fixative/
  49. https://www.emsdiasum.com/hollandes-fixative
  50. https://www.statlab.com/pdfs/ifu/FXHOL.pdf
  51. https://chaptec.com/usa/prod/3707/hollandes-fixative.html
  52. https://www.morphisto.de/en/shop/detail/d/BOUIN-HOLLANDE_Fixierl%25C3%25B6sung_f%25C3%25BCr_die_IHC//9813/
Add your contribution
Related Hubs
User Avatar
No comments yet.